Occudo Quantitative Strategies LP Assembly Biosciences, Inc. Transaction History

Occudo Quantitative Strategies LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$1.7 - $20.52 $21,148 - $255,268	12,440 New	12,440 $20,000
Q3 2021 Nov 15, 2021	SELL	$3.14 - $3.9 $281,036 - $349,057	-89,502 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$3.8 - $4.56 $29,260 - $35,112	-7,700 Reduced 7.92%	89,502 $347,000
Q1 2021 May 14, 2021	BUY	$4.33 - $6.63 $201,778 - $308,958	46,600 Added 92.09%	97,202 $447,000
Q4 2020 Feb 16, 2021	BUY	$4.87 - $17.29 $246,431 - $874,908	50,602 New	50,602 $306,000

16.3K

Ticker ASMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,436,900
Market Cap $717M
Description
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

Stay updated on Occudo Quantitative Strategies LP with notifications on news.